Drugs / ITX24-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07520240 | Jun 2026 → Jan 2027 expected | — | Interventional AnalgesiX Inc. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ITX24-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07520240 ↗ |
| Route | Other | “ITX24-01 administered via the medial branch block (MBB) route” NCT07520240 ↗ |